In this week’s Solidarity Fridays episode, Joe Moore and David Drapkin interview Numinus Co-founder and CEO, Payton Nyquvest. Joe and Kyle Buller first discuss upcoming courses, Wonderland, Covid, whether or not psychedelics are in an “ivory tower,” and Mike Tyson: his insistence on saying “toad” and his relationship to Gerry Sandoval. Then, Joe and David speak with Payton Nyquvest of Numinus, a company that offers ketamine-assisted psychotherapy and features Numinus Biosciences, which recently produced the first legal psilocybin product derived from natural psilocybin-producing mushrooms. Nyquvest discusses how his mother’s substance abuse recovery and a trip to an ayahuasca retreat center taught him how to reimagine his chronic pain as a gift, psilocybin, and more.

The post PTSF86 – Ayahuasca, Chronic Pain, and Legal Psilocybin, with Payton Nyquvest of Numinus appeared first on Psychedelics Today.

Previous articleSeelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note
Next articleNuminus Receives Conditional Approval to Graduate to the Toronto Stock Exchange